Plymouth Buys iSOFT Business Intelligence to Raise Labs Performance

iSOFTiSOFT, a CSC company, has agreed a deal with Plymouth Hospitals NHS Trust for a business intelligence tool to boost performance across its busy laboratory departments to deliver continuous service improvements.

Drawing information from the iSOFT laboratory system at Plymouth, the new solution will provide a dashboard to monitor key performance indicators in real time. This includes the turnaround times of test samples to guarantee targets are met. The trust faces local and national NHS targets for A&E specimens for instance, plus contractual targets for commercial treatment centres and private healthcare firms.

"The iSOFT solution will allow us to proactively manage specimens to identify potential breaches in turnaround times before they become critical," said Adrian Heathcote, the trust's pathology IT manager. "This represents a fundamental shift in ethos.

"It is impossible to monitor targets in real time using the data extract tools commonly found in pathology departments, so breaches only become apparent after the event," he added. "The solution will help mitigate risk and is an additional tool to help us continue with our other customer-focused service improvements."

A second phase will see iSOFT's laboratory business intelligence solution used to optimise workflows and improve performance. This includes plans to examine demand to ensure the right people and skills are in place at peak times and to pinpoint bottlenecks.

The solution will used across all three laboratories at Plymouth's Derriford Hospital and across all laboratory disciplines, including histopathology, microbiology, haematology, and clinical biochemistry. The trust's Pathology Directorate employs 257 staff and conducts 6.5 million tests on 1.3 million specimens a year.

"Seventy to eighty percent of diagnoses now rely on pathology tests and the pressure on laboratory services will only intensify," said Adrian Stevens, managing director of iSOFT's UK business. "Our solution gives pathology departments the means to remove inefficiencies and find savings.

"As an early adopter, we will work closely with Plymouth to further shape the product to meet specific NHS needs."

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...